Skip to content

The effectiveness evaluation and standardization research of new rehabilitation therapy for the speech-language disorders or gait disorders in mid- to late-stage Parkinson’s disease patients

The effectiveness evaluation and standardization research of new rehabilitation therapy for the speech-language disorders or gait disorders in mid- to late-stage Parkinson’s disease patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800017031
Enrollment
Unknown
Registered
2018-07-09
Start date
2018-07-01
Completion date
Unknown
Last updated
2018-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson‘s disease

Interventions

Rehabilitation group (speech-language disorders):Anti-parkinson drugs plus LSVT
Control group (speech-language disorders):Anti-parkinson drugs
Rehabilitation group (gait disorders):Anti-parkinson drugs plus intensive exercise combined with VR therapy
Control group (gait disorders):Anti-parkinson drugs

Sponsors

Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged 45 or older, male or female; 2. Diagnosed as idiopathic Parkinson's disease(Clinically Established PD or Clinically Probable PD) with speech-language disorders or gait disorders according to the 2015 MDS Clinical Diagnostic Criteria for Parkinson's disease; 3. With the modified Hoehn & Yahr (H&Y) staging 2.5-5; 4. Each subject or his/her legal guardian agrees to participate in this study and signs the written informed consent for participation.

Exclusion criteria

Exclusion criteria: 1. Secondary Parkinsonismcaused by vascular factors, toxins and drugs et al., or Parkinsonism-plus Syndrome; 2. Disorders of consciousness, severe organic diseases, cerebral hemorrhage, cerebral ischemic stroke, severe heart and lung diseases, severe liver and kidney dysfunction, severe diabetes, severe hearing and visual impairment; 3. With a history of severe brain tumors or brain surgery; 4. According to the researchers'judgment, those who may not complete the study in accordance with the requirements of the study protocol.

Design outcomes

Primary

MeasureTime frame
Gait speed;The time in "Timed up and go test";UPDRS II & III;LSVT-Loud Praat Analysis;Perceptual Rating Form (VAS);

Secondary

MeasureTime frame
The modified Hoehn & Yahr scale (H&Y) ;39-item Parkinson's disease questionnaire (PDQ-39);Voice Handicap Index (VHI);

Countries

China

Contacts

Public ContactQing Wang

Zhujiang Hospital of Southern Medical University

wqdennis@hotmail.com+86 13829734526

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026